A 38-year-old woman presents with weeks of migratory joint pain, morning stiffness lasting 90 minutes, and symmetrical swelling of the wrists and metacarpophalangeal joints. Rheumatoid factor and anti-CCP antibodies are positive, and inflammatory markers are elevated. According to Canadian rheumatology guidance, what is the most appropriate initial disease-modifying treatment?